1. FOLFIRINOX and translational studies: Towards personalized therapy in pancreatic cancer
   Chiara Caparello et al, 2016, WJG CrossRef
2. Imaging EGFR and HER3 through 89Zr-labeled MEHD7945A (Duligotuzumab)
   Brooke N. McKnight et al, 2018, Sci Rep CrossRef
3. Rethink of EGFR in Cancer With Its Kinase Independent Function on Board
   Rintu Thomas et al, 2019, Front. Oncol. CrossRef
4. NIR Photodynamic Destruction of PDAC and HNSCC Nodules Using Triple-Receptor-Targeted Photoimmuno-Nanoconjugates: Targeting Heterogeneity in Cancer
   Shazia Bano et al, 2020, JCM CrossRef
5. Epidermal Growth Factor Receptor Expression and Resistance Patterns to Targeted Therapy in Non-Small Cell Lung Cancer: A Review
   Emma-Anne Karlsen et al, 2021, Cells CrossRef
6. The Combination of Epidermal Growth Factor Receptor Inhibitors with Gemcitabine and Radiation in Pancreatic Cancer
   Meredith A. Morgan et al, 2008 CrossRef
7. Targeted delivery of therapeutic oligonucleotides in pancreatic cancer
   Yang Iris, 2022, J Biol Med CrossRef
8. Dual Targeting of the EGFR/HER2 Pathway in Combination with Systemic Chemotherapy in Refractory Pancreatic Cancer—The CONKO-008 Phase I Investigation
   Jana K. Striefler et al, 2022, JCM CrossRef